EHTIC study: Evaluation of a new hemostatic agent based on tissue factor in skin grafting procedures

The new hemostatic agent TT-173 has proven efficacious and safe to reduce the bleeding from donor site. This study paves the way for further investigation of the product as topical hemostatic treatment in plastic surgery and other surgical indications.